Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF) (2018 - 2019)

Historic Depreciation & Amortization (CF) for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $5000.0.

  • DiaMedica Therapeutics' Depreciation & Amortization (CF) changed 0.0% to $5000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $21000.0, marking a year-over-year increase of 4000.0%. This contributed to the annual value of $39000.0 for FY2024, which is 3000.0% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Depreciation & Amortization (CF) of $5000.0 as of Q4 2019, which was down 0.0% from $5000.0 recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Depreciation & Amortization (CF) peaked at $6000.0 during Q1 2019, and registered a low of $2000.0 during Q2 2018.